Psychedelic Research Proves Rather Tricky for the FDA
April 30, 2024
No Comments
Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.
Tag: Multidisciplinary Association for Psychedelic Substances
MAPS Study Shows Benefits of Using MDMA To Treat PTSD
September 26, 2023
No Comments
MAPS is now on track to proposing MDMA as a treatment for PTSD from the FDA in 2024.
Psychedelic Research Proves Rather Tricky for the FDA
April 30, 2024
No Comments
Nasty claims of bias and impartial research stand in the way of MDMA gaining FDA clearance for PTSD.
MAPS Study Shows Benefits of Using MDMA To Treat PTSD
September 26, 2023
No Comments
MAPS is now on track to proposing MDMA as a treatment for PTSD from the FDA in 2024.
Subscribe to High Times
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!